Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Todd M Morgan

Showing results (251-260 of 307) with videos related to

Pageof 31
Sort By:
European Urology|July 24, 2018
Targeted DNA and RNA Sequencing of Paired Urothelial and Squamous Bladder Cancers Reveals Discordant Genomic and Transcriptomic Events and Unique Therapeutic ImplicationsDaniel H Hovelson, Aaron M Udager, Andrew S McDaniel, et al.
JCI Insight|November 3, 2018
Transcriptomic heterogeneity in multifocal prostate cancerSimpa S Salami, Daniel H Hovelson, Jeremy B Kaplan, et al.
Nature Communications|May 21, 2024
Integrative multi-region molecular profiling of primary prostate cancer in men with synchronous lymph node metastasisUdit Singhal, Srinivas Nallandhighal, Jeffrey J Tosoian, et al.
Cancer Medicine|April 25, 2022
Germline mutations in penetrant cancer predisposition genes are rare in men with prostate cancer selecting active surveillanceLauren Brady, Lisa F Newcomb, Kehao Zhu, et al.
International Journal of Radiation Oncology, Biology, Physics|July 25, 2022
A Phase I Trial of Neoadjuvant Stereotactic Body Radiotherapy Prior to Radical Prostatectomy for Locally Advanced Prostate CancerLiat Hammer, Ralph Jiang, Jason Hearn, et al.
JCO Precision Oncology|June 6, 2025
Cross-Comparison Individual Patient-Level Analysis of Three Gene Expression Signatures in Localized Prostate in Over 50,000 MenAngela Y Jia, Yilun Sun, Maitry Patel, et al.
JCO Precision Oncology|October 24, 2024
Prostate Cancer Risk Stratification in NRG Oncology Phase III Randomized Trials Using Multimodal Deep Learning With Digital HistopathologyJonathan David Tward, Huei-Chung Huang, Andre Esteva, et al.
European Urology|October 8, 2024
Impact of Gene Expression Classifier Testing on Adjuvant Treatment Following Radical Prostatectomy: The G-MINOR Prospective Randomized Cluster-crossover TrialTodd M Morgan, Stephanie Daignault-Newton, Daniel E Spratt, et al.
International Journal of Surgical Pathology|October 17, 2022
Characterization of Intercalated Cell Markers KIT and <i>LINC01187</i> in Chromophobe Renal Cell Carcinoma and Other Renal NeoplasmsRahul Mannan, Xiaoming Wang, Pushpinder S Bawa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 14, 2019
Transcriptomic Heterogeneity of Androgen Receptor Activity Defines a <i>de novo</i> low AR-Active Subclass in Treatment Naïve Primary Prostate CancerDaniel E Spratt, Mohammed Alshalalfa, Nick Fishbane, et al.
Pageof 31

Showing results (251-260 of 307) with videos related to

Sort By:
Pageof 31
European Urology|July 24, 2018
Targeted DNA and RNA Sequencing of Paired Urothelial and Squamous Bladder Cancers Reveals Discordant Genomic and Transcriptomic Events and Unique Therapeutic ImplicationsDaniel H Hovelson, Aaron M Udager, Andrew S McDaniel, et al.
JCI Insight|November 3, 2018
Transcriptomic heterogeneity in multifocal prostate cancerSimpa S Salami, Daniel H Hovelson, Jeremy B Kaplan, et al.
Nature Communications|May 21, 2024
Integrative multi-region molecular profiling of primary prostate cancer in men with synchronous lymph node metastasisUdit Singhal, Srinivas Nallandhighal, Jeffrey J Tosoian, et al.
Cancer Medicine|April 25, 2022
Germline mutations in penetrant cancer predisposition genes are rare in men with prostate cancer selecting active surveillanceLauren Brady, Lisa F Newcomb, Kehao Zhu, et al.
International Journal of Radiation Oncology, Biology, Physics|July 25, 2022
A Phase I Trial of Neoadjuvant Stereotactic Body Radiotherapy Prior to Radical Prostatectomy for Locally Advanced Prostate CancerLiat Hammer, Ralph Jiang, Jason Hearn, et al.
JCO Precision Oncology|June 6, 2025
Cross-Comparison Individual Patient-Level Analysis of Three Gene Expression Signatures in Localized Prostate in Over 50,000 MenAngela Y Jia, Yilun Sun, Maitry Patel, et al.
JCO Precision Oncology|October 24, 2024
Prostate Cancer Risk Stratification in NRG Oncology Phase III Randomized Trials Using Multimodal Deep Learning With Digital HistopathologyJonathan David Tward, Huei-Chung Huang, Andre Esteva, et al.
European Urology|October 8, 2024
Impact of Gene Expression Classifier Testing on Adjuvant Treatment Following Radical Prostatectomy: The G-MINOR Prospective Randomized Cluster-crossover TrialTodd M Morgan, Stephanie Daignault-Newton, Daniel E Spratt, et al.
International Journal of Surgical Pathology|October 17, 2022
Characterization of Intercalated Cell Markers KIT and <i>LINC01187</i> in Chromophobe Renal Cell Carcinoma and Other Renal NeoplasmsRahul Mannan, Xiaoming Wang, Pushpinder S Bawa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 14, 2019
Transcriptomic Heterogeneity of Androgen Receptor Activity Defines a <i>de novo</i> low AR-Active Subclass in Treatment Naïve Primary Prostate CancerDaniel E Spratt, Mohammed Alshalalfa, Nick Fishbane, et al.
Pageof 31